Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function
Rational Inhibition of renin–angiotensin system (RAS) improves cognitive functions in
hypertensive patients. However, role of AT1 and AT2 receptors in memory impairment due to …
hypertensive patients. However, role of AT1 and AT2 receptors in memory impairment due to …
Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral …
Evidences indicate that inhibition of central Renin angiotensin system (RAS) ameliorates
memory impairment in animals and humans. Earlier we have reported involvement of central …
memory impairment in animals and humans. Earlier we have reported involvement of central …
[PDF][PDF] Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer's disease
CARDIOVASCULAR RISK FACTORS AS POTENTIAL MARKERS FOR MILD COGNITIVE
IMPAIRMENT AND ALZHEIMER’S DISEASE Page 1 340 Psychiatria Danubina, 2011; Vol. 23 …
IMPAIRMENT AND ALZHEIMER’S DISEASE Page 1 340 Psychiatria Danubina, 2011; Vol. 23 …
Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration
A Hariharan, S Shetty, T Shirole, AG Jagtap - Neurotoxicology, 2014 - Elsevier
Huntington's disease (HD) is a genetic, neurodegenerative disorder mainly characterized by
motor dysfunction, cognitive decline and psychiatric disturbances. 3-Nitropropionic acid (3 …
motor dysfunction, cognitive decline and psychiatric disturbances. 3-Nitropropionic acid (3 …
The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis?
PG Kehoe, PA Passmore - Journal of Alzheimer's Disease, 2012 - content.iospress.com
There is an urgent need to improve upon Alzheimer's disease (AD) treatments. Limitations of
existing drugs are that they target specific downstream neurochemical abnormalities while …
existing drugs are that they target specific downstream neurochemical abnormalities while …
Neurovascular and cognitive failure in Alzheimer's disease: benefits of cardiovascular therapy
E Hamel, J Royea, B Ongali, XK Tong - Cellular and molecular …, 2016 - Springer
Alzheimer's disease (AD) is a multifactorial and multifaceted disease for which we currently
have very little to offer since there is no curative therapy, with only limited disease-modifying …
have very little to offer since there is no curative therapy, with only limited disease-modifying …
Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease
EL Ashby, PG Kehoe - Expert opinion on investigational drugs, 2013 - Taylor & Francis
Introduction: Hypertension is a modifiable risk factor for Alzheimer's disease (AD) and other
dementias. Yet, despite this well-documented association, few of the current strategies to …
dementias. Yet, despite this well-documented association, few of the current strategies to …
[HTML][HTML] The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections
Cardiovascular (CV) diseases and mood disorders are common public health problems
worldwide. Their connections are widely studied, and the role of neurotrophins (NTs) is …
worldwide. Their connections are widely studied, and the role of neurotrophins (NTs) is …
[HTML][HTML] The Emerging Evidence for a Protective Role of Fucoidan from Laminaria japonica in Chronic Kidney Disease-Triggered Cognitive Dysfunction
Z Ma, Z Yang, X Feng, J Deng, C He, R Li, Y Zhao… - Marine Drugs, 2022 - mdpi.com
This study aimed to explore the mechanism of fucoidan in chronic kidney disease (CKD)-
triggered cognitive dysfunction. The adenine-induced ICR strain CKD mice model was …
triggered cognitive dysfunction. The adenine-induced ICR strain CKD mice model was …
An update of the role of renin angiotensin in cardiovascular homeostasis
E Farag, K Maheshwari, J Morgan, WAS Esa… - Anesthesia & …, 2015 - journals.lww.com
The renin angiotensin system (RAS) is thought to be the body's main vasoconstrictor system,
with physiological effects mediated via the interaction of angiotensin II with angiotensin I …
with physiological effects mediated via the interaction of angiotensin II with angiotensin I …